PT  - JOURNAL ARTICLE
AU  - Ricardo Villela
AU  - Ricardo Correa
TI  - Semaglutide 2.4 mg: the latest GLP-1RA approved for obesity
AID  - 10.1136/jim-2021-002227
DP  - 2022 Jan 01
TA  - Journal of Investigative Medicine
PG  - 3--4
VI  - 70
IP  - 1
4099  - http://hw-f5-jim.highwire.org/content/70/1/3.short
4100  - http://hw-f5-jim.highwire.org/content/70/1/3.full
SO  - J Investig Med2022 Jan 01; 70